Cite Filings / ACXP
Feed Companies Filings Check
Sign in

CIK 0001736243 · <br>Emerging growth company

Acurx Pharmaceuticals, Inc.

Sign in to watch
Ticker
ACXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
917-533-1469
Business address
259 LIBERTY AVENUE, STATEN ISLAND, NY, 10305
Former names
Acurx Pharmaceuticals, LLC
Filings Insiders Search text
All 246 Financials 60 Shareholder Meetings 9 Executive Compensation 49 Insider Trading 59 Beneficial Ownership Interest 13 Business Combinations 38 Public Offerings 62 Mutual Funds and ETFs 6 Others 49
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-09-01
  3. DEF 14A Proxy Proxy Statement 2025-08-04
  4. PRE 14A Proxy Proxy Statement (Preliminary) 2025-07-24
  5. DEF 14A Proxy Proxy Statement 2025-05-29
  6. PRE 14A Proxy Proxy Statement (Preliminary) 2025-05-19
  7. DEF 14A Proxy Proxy Statement 2024-04-29
  8. DEF 14A Proxy Proxy Statement 2023-04-27
  9. PRE 14A Proxy Proxy Statement (Preliminary) 2023-04-17
  10. DEF 14A Proxy Proxy Statement 2022-04-25

Page 1 of 1 · 9 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…